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Spina bifida (SB) is a birth abnormality, including failure of closure at the spinal level (SL), craniorachischisis, failure of neural tube closure (NTC), body axis, exencephaly, and failure of the cranial neural folds, and represents a great challenge in the regulation of cell and tissue behaviors.\[[@ref1]\] The maternal genetic variants of enzymes in folate--homocysteine metabolic network are associated with the risk of SB already documented.\[[@ref2]\] Bioinformatics techniques are now used to explore the molecular etiopathogenesis of the potential genetic risk pattern of developing SB; genomic test revealed that Arg2del variant kept subcellular localization unaltered within the catalytic activity intact and failed to efficiently activate 5-Methyltetrahydrofolate-Homocysteine Methyltransferase (MTR) compared with the wild type.\[[@ref3]\] SB is the genetic disorder of folate and homocysteine metabolism (FHM) during pregnancy and is associated with folate-sensitive neural tube defects (FSNTDs) located in-frame deletion in methionine synthase reductase (MTRR) exon 1 as higher risk factor susceptibility to SB.\[[@ref4]\] SB frequency is approximately 1--3 in 1000 live births in US.\[[@ref5]\] In India, it is approximately 3.9--8.8 per 1000 live births.\[[@ref6]\] Neural tube (NT) malformations involving the spinal cord and the vertebral arches are referred to as SB.\[[@ref7]\]

SB involved within the protrusion of the spinal cord and/or meninges through a defect in the vertebral arch at the level of the lesion, interruption of the spinal cord at the site of the spina bifida defect (SBD) causes paralysis of the legs, incontinence of urine and feces, anesthesia of the skin, and abnormalities of the hips, knees, and feet. Abnormalities seen in children with SB include hydrocephalus and the Arnold--Chiari type II malformation.\[[@ref8]\] Molecular basis of SB is a complex and heterogeneous condition. *Grainyhead*-like genes represent candidates for the SB and exencephaly; carrying loss-of-function alleles of *Grhl2* or *Grhl3* expression in bacterial artificial chromosome--mediated transgenesis prevents SB but *Grhl3* overexpression at the *Vangl2Lp* allele causes SB.\[[@ref9]\]

Folic acid supplements (FASs) helps to prevent the SB, NTDs, by stimulating the methylation reactions, methylome analysis for patients with myelomeningocele (MMC) by candidate CpG analysis for *HOX* genes associations at *HOXB7* hypomethylation in MMC was found.\[[@ref10]\] Leukocyte methylome data CpG-specific methylation replicated candidate genes are *ABAT, CNTNAP1, SLC1A6, SNED1, SOX18, TEPP* within the MMC patients respectfully.\[[@ref11]\] Genome-wide methylation study observed that leukocytes in patients with NTDs and SB had *SOX18* gene sequence that resulted in hypomethylation, which interplayed with environmental and epigenetic factors to cause NTDs and SB.\[[@ref12]\]

The tumor suppressor protein Scribble (SCRIB) plays conserved role in cell polarity. The mutations pattern at SCRIB SADH domains is associated with SB and cancer.\[[@ref10]\] The water-insoluble proteins are located on the surface of rubber particles in *Hevea brasiliensis* latex. One particle, 14.6 kd protein (Hev b 1), seen on large rubber particles (\>350mm in diameter) and second particle, 24 kd protein (Hev b 3), found mainly on small rubber particles (average diameter, 70nm) are recognized by the immunoglobulin E in the patients with SB and latex allergy.\[[@ref11]\]

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

SB (spinal neural tube defects \[NTDs\]) basically is caused by an abnormality at the closure of the NT.

Molecular researchers were trying to know the new etiopathogenesis of the SB (spinal NTDs) and defective NTC.

*Inclusion criteria*: We included different molecular aspects of SB from available tools and databases.

*Exclusion criteria*: We excluded case reports and irrelevant studies.

*Statistical analysis*: We used simple statistics (percentage, mean, median, and average) through the Statistical Package for the Social Sciences (SPSS) software, version 15, SPSS Inc. 2006, Illinois, Chicago, and found *P* \>0.0001 to be significant.
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=====================

Genetic disorder of FHM during pregnancy is believed to be associated with the FSNTDs and SB. The report highlighted that the in-frame deletion in MTRR exon 1, a high-risk factor susceptible to the SB, is more than 90% of the original contributions.\[[@ref12]\]

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Exogenous retinoic acid induces the anterior (anencephaly and exencephaly) and posterior (SB) NTDs depending on the developmental stage of treatment.\[[@ref13]\] Informative bio markers retinoic acid-treated wild-type and RARgamma-/- embryos indicated that treatment of wild-type embryos led to decrease the caudal expression, mesodermal biomarkers examined for brachyury, *wnt-3a*, *cdx-4* somite, neuroepithelial, notochord, floorplate, and hindgut markers were unaffected.\[[@ref14]\] Transcripts encoding mP450RAI, a cytochrome P450, catabolize retinoic acid, abundant in the retinoid-poor region caudal embryo, and generate posterior mesoderm derivatives in part by affecting brachyury expression.\[[@ref15]\]

*GRHL3* in the whole gene and the transactivation region in the data of the patients with SB provide a strong role as a predisposing factor to SB and help to dissect the complex etiology and pathogenic mechanisms of these malformations.\[[@ref16]\] DVL1/2 mRNA levels are correlated with the levels of serine/threonine protein kinase, MARK2, and cases with human lumbosacral and SB.\[[@ref17]\]*FZD3* gene and planar cell polarity signaling pathway in convergent extension are involved with genetic and epigenetic mechanisms associated with human NTDs, but DNA methylation had important role in *FZD3* gene, that is, to express and regulate SB.\[[@ref18]\]

The transcription regulatory regions of *TRIM26* and *GNAS* were at the hypomethylation status located in SB placenta but protein levels of TRIM26 and GNAS were elevated only in the SB placenta but not in the SB-affected fetuses. In CHO cells are deficienting in dihydrofolate reductase and treated with 5-aza-2'-deoxycytidine, the findings regarding the protein levels of GNAS and TRIM26 suggested that epigenetic status of genes in placenta helps in the development of NTDs.\[[@ref19]\]

The small molecules, microRNA-7 (miR-7), microRNA-375 (miR-375), and microRNA-451 (miR-451), downregulate 14-3-3ζ. p53 expression is downstream of 14-3-3ζ and downregulates the reduction of 14-3-3ζ expression, the expression of miR-451, miR-375, and p53 is increased in SB in rat fetuses. Expression of 14-3-3ζ in the excessive apoptosis has major role in the SB due to over-expression of miR-451 and miR-375, consequent upregulation of p53 might further promote apoptosis in SB.\[[@ref20]\] Novel missense mutation (p.A1257T) was detected in control samples, and it was predicted to be benign rare deleterious mutation of SCRIB, which contribute to the multifactorial risk for human SB \[[Table 1](#T1){ref-type="table"}\].\[[@ref17][@ref21]\] In both animals and humans, *PAX3* and *T* (brachyury) are the candidate genes for SB.\[[@ref22]\]

###### 

Majority of responsible genes involved with SB, NTDs, NTC

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  S. no.   Responsible gene   Chromosomal location   Mutagenicity/polymorphism                                                                                     Diseases specific
  -------- ------------------ ---------------------- ------------------------------------------------------------------------------------------------------------- -------------------
  1\.      *MTRR*             Exon 1                 In-frame trinucleotide deletion (c.4_6delAGG)\                                                                SB
                                                     (a 66A-G polymorphism), resulting in an ile22-to-met (I22M) substitution                                      

  2\.      *MTHFR*            1p36.22\               C677T\                                                                                                        SB\
                              T allele               Homozygous (TT) and heterozygous (CT) genotypes\                                                              NTDs\
                                                     wild type (CC) genotype                                                                                       NTC

  3\.      *GRHL2*            8q22                   Mutant alleles of Grhl2 and Vangl2 in mice\                                                                   SB\
                                                     Y398H (608576.0003) and I482K (608576.0004) missense mutation                                                 NTDs

  4\.      *GRHL3*            1p36.11\               Mutant alleles of Grhl2 and Vangl2 in mice\                                                                   SB\
                              Exon9                  arg391-to-cys (R391C) substitution                                                                            NTDs

  5\.      *HOX*              Candidate CpG          HOXB7 hypomethylation                                                                                         MMC

  6\.      *ABAT*             16p13.3                R377W; 137150.0008 (homozygous mutation)\                                                                     SB
                                                     (137150.0005-137150.0006 (heterozygous mutation)                                                              

  7\.      *CNTNAP1*          17q21                  (R388P; 602346.0008)\                                                                                         SB
                                                     Missense mutation                                                                                             

  8\.      *SLC1A6*           19p13.12               Carboxy 77 amino acids of EAAT4. GTRAP41 (SPTBN2; 604985) and GTRAP48 (605708) increase glutamate transport   CBM\
                                                                                                                                                                   CNS

  9\.      *SNED1*            2q37.3                 Exon 16 is subject to alternative splicing (CCP domain)                                                       E

  10\.     *SOX18*            20q13.3                Homozygous missense mutations (A104P, 601618.0001 and W95R, 601618.0002)                                      D
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MTHFR = methylene tetrahydrofolate reductase, GRHL2 = Grainyhead-like 2, GRHL3 = Grainyhead-like 3, HOX = homeobox genes, ABAT = gamma-aminobutyrate transaminase, CNTNAP1 = contactin associated protein 1, SLC1A6 = solute carrier family 1 member 6 (HGNC symbol), SNED1 = stromal nidogen extracellular matrix protein, SOX18 = transcription factor SOX-18, CBM = cerebellum, CNS = central nervous system, E = embryogenesis, D = development
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Dorsal spinous process schisis is a rare vertebral abnormality recognized by X-rays in the imaging study of the lung parenchyma anatomical variation; T1 SB occulta is also seen few times.\[[@ref23]\] SB as the second most common group of congenital anomalies may be diagnosed by prenatal ultrasonography and may be associated with chromosomal abnormalities, including full and partial aneuploidies with syndromic SB associated with partial 3q duplication and partial 5p deletion, and emphasizes the consistency in the prenatal sonographic feature of SB in consecutive pregnancies with fetuses associated with the partial trisomy 3q (3q26.1-qter) and partial monosomy 5p (5p13.33-pter). The use of molecular cytogenetic technologies, such as array comparative genomic hybridization and fluorescence in situ hybridization, is important for clarifying any type of unbalanced chromosome rearrangement, which is one of the positive sides of investigation of SB and NTC.\[[@ref24]\] PDGFRα downstream effectors, PI3K, are essential for cell migration of a somite-derived dorsal mesenchyme, and disruption of receptor signaling in these cells leads to SB\[[@ref25]\] Maternal use of antiepileptic drugs (AEDs) during pregnancy is associated with major congenital malformations in children, certain AEDs are associated with increased rates of congenital malformations (SB, cardiac anomalies).\[[@ref26]\]

*Limitations*: More studies will be required to determine whether these variants are influencing the risk of SB in Indian prospective.

C[ONCLUSION]{.smallcaps} {#sec1-6}
========================

We concluded that direct interactions of the downstream target sites among few responsible regulating genes' unique pattern of biology and their genetic road map control guide the neurulation and provide further insights for the causes of SB and help to develop new molecular-targeted therapy. The spectrum of mutant combined evidence in mutant models supports the congenital anomalies that may originate from perturbations of mesoderm specification, epithelial-mesenchymal transition, and mesodermal cell migration, which are responsible in molecular pathways needed to improve strategies for the prevention of major structural birth defects. Original studies will be required to determine whether these variants are influencing the risk of SB in Indian patient or not and this is stillan interesting research area that need to be improved through next-generation sequencing or genome wide association study or recent new innovative tools and techniques.
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